Orchestra BioMed Holdings, Inc. ( OBIO) - Stock Earnings
OBIO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 9, 2026, midnight | — / — | — | — / — | — |
OBIO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 6.2 million USD | 30.9 million USD |
| 2026Q1 | -20.7 million USD | 110000 USD |
| 2026Q2 | -23.8 million USD | 88000 USD |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OBIO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -49.1 million USD | 2.8 million USD |
| 2024 | -61.0 million USD | 2.6 million USD |
| 2025 | -52.7 million USD | 33.5 million USD |
| 2026 Est. | — | — |
OBIO
Price: $5.45
52 week price:
Earnings Per Share: -0.84 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 356.3 million